Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Piperazine compounds as drugs of abuse
Publication

Publications

Piperazine compounds as drugs of abuse

Title
Piperazine compounds as drugs of abuse
Type
Another Publication in an International Scientific Journal
Year
2012
Authors
Arbo, MD
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Bastos, ML
(Author)
FFUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Vol. 122
Pages: 174-185
ISSN: 0376-8716
Publisher: Elsevier
Scientific classification
FOS: Medical and Health sciences > Clinical medicine
Other information
Authenticus ID: P-002-ANZ
Abstract (EN): Synthetic drugs are among the most commonly abused drugs in the world. This abuse is widespread among young people, especially in the dance club and rave scenes. Over the last several years, piperazine derived drugs have appeared, mainly available via the internet, and sold as ecstasy pills or under the names of "Frenzy", "Bliss", "Charge", "Herbal ecstasy", "A2", "Legal X" and "Legal E". Although in the market piperazine designer drugs have the reputation of being safe, several experimental and epidemiological studies indicate risks for humans. Piperazine designer drugs can be divided into two classes, the benzylpiperazines such as N-benzylpiperazine (BZP) and its methylenedioxy analogue 1-(3,4-methylenedioxybenzyl)piperazine (MDBP), and the phenylpiperazines such as 1-(3-chlorophenyl)piperazine (mCPP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP), and 1-(4-methoxyphenyl)piperazine (MeOPP). Toxicokinetic properties, including metabolic pathways, actions and effects in animals and humans, with some hypothesis of mechanism of action, and analytical approaches for the identification of these drugs are summarized in this review.
Language: English
Type (Professor's evaluation): Scientific
Contact: m.arbo@terra.com.br
No. of pages: 12
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Hepatotoxicity of piperazine designer drugs: up-regulation of key enzymes of cholesterol and lipid biosynthesis (2016)
Article in International Scientific Journal
Arbo, MD; Melega, S; Stoeber, R; Schug, M; Rempel, E; Rahnenfuehrer, J; Godoy, P; Reif, R; Cadenas, C; Maria de Lourdes Bastos; Helena Carmo; Hengstler, JG
Hepatotoxicity of piperazine designer drugs: Comparison of different in vitro models (2015)
Article in International Scientific Journal
Dias da Silva, D; Arbo, MD; Valente, MJ; Bastos, ML; Carmo, H

Of the same journal

Drinking to death: Hyponatraemia induced by synthetic phenethylamines (2020)
Another Publication in an International Scientific Journal
Faria, AC; Helena Carmo; Carvalho, F; Silva, JP; Bastos, MDL; Dias da Silva, D
Manufactured and hand-rolled cigarettes and smokeless tobacco consumption in Mozambique: Regional differences at early stages of the tobacco epidemic (2011)
Article in International Scientific Journal
Araujo, C; Silva Matos, C; Damasceno, A; Gouveia, ML; Azevedo A; Lunet N
Alcohol consumption in Mozambique: regular consumption, weekly pattern and binge drinking. (2010)
Article in International Scientific Journal
Padrão P; Damasceno A; Silva-Matos C; Laszczyńska O; Prista A; Gouveia L; Lunet N

See all (7)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-08-06 at 04:19:48 | Privacy Policy | Personal Data Protection Policy | Whistleblowing